Utah Medical Products, Inc.

UTMD Healthcare Medical Instruments & Supplies

Utah Medical Products, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.5 million, down 5.83% from fiscal 2024.

Revenue
−14.3%
EPS
−10.6%
Free cash flow
−55.7%

Quarter to June 2026, against a year earlier

72.04 1.00 +1.41%
Market cap
$202.4M
P/E
21.7×
Fwd P/E
28.7×
Dividend yield
1.74%
F-score
6/9
Altman Z
36.25
Beneish M
−2.68
Dividend safety
82/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

6 6 6 7
ROE
9.59% 9.54% 9.14% 8.75%
ROA
9.24% 9.21% 8.79% 8.55%
ROIC
21.87% 21.26% 20.50% 18.60%
Return on Tangible Assets
11.23% 10.74% 10.18% 9.69%
Average Days of Receivables
35.19 33.37 35.36 36.04
Free Cash Flow per Share
4.33 4.42 4.09 3.60
Free Cash Flow
13.88 14.32 13.02 11.45
Other line items

Show all line items

Columns are period end dates